Literature DB >> 22559040

CD44s and CD44v6 in diagnosis and prognosis of human bladder cancer.

Ola M Omran1, Hesham S Ata.   

Abstract

UNLABELLED: The cell adhesion molecules (CAMs) CD44 standard (CD44s) and its variant 6 (CD44v6) are involved in the progression and invasion of human malignancies. However, discrepancies in the prognostic value of CD44s and CD44v6 expression need to be addressed. AIMS: To investigate the expression of CD44s and CD44v6 in bladder carcinomas and relate the results to the established prognostic factors.
MATERIALS AND METHODS: 50 bladder carcinoma specimens, 30 cases with transitional cell carcinoma (TCC: 6 bilharzial and 24 nonbilharzial) and 20 cases with squamous cell carcinoma (SCC: 8 bilharzial and 12 nonbilharzial), were included. Immunohistochemical analysis for CD44s and CD44v6 was carried out using avidin-biotin peroxidase method.
RESULTS: The level of both CD44s and CD44v6 in TCC was significantly higher in invasive than in preinvasive tumors and normal urothelium (p < .05). A direct association between the percentage of expression of both markers and the grade of TCC (p < .05) was observed. An inverse correlation between CD44s and SCC was seen, where metaplastic urothelium showed higher expression than invasive carcinomas. No association was observed between the expressions of both CD44s and CD44v6 and bilharzial ova, sex and age of the patient, or size of the tumor.
CONCLUSIONS: The authors report statistically significant correlation between CD44s and CD44v6 expression and increasing grade and stage of TCC. No such correlation with SCC and with bilharzial cystitis, sex and age of the patient, or size of the tumor was documented.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22559040     DOI: 10.3109/01913123.2011.651522

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN: 0191-3123            Impact factor:   1.094


  11 in total

Review 1.  Alternative splicing modulates cancer aggressiveness: role in EMT/metastasis and chemoresistance.

Authors:  Debanwita Roy Burman; Shalini Das; Rahul Bhattacharya; Chandrima Das
Journal:  Mol Biol Rep       Date:  2021-01-05       Impact factor: 2.316

2.  Relationship of PCNA, C-erbB2 and CD44s expression with tumor grade and stage in urothelial carcinomas of the bladder.

Authors:  Ayhan Yıldırım; Mustafa Kösem; Ilyas Sayar; Ibrahim Gelincik; Alparslan Yavuz; Aliseydi Bozkurt; Unal Erkorkmaz; Irfan Bayram
Journal:  Int J Clin Exp Med       Date:  2014-06-15

3.  CD44v6 expression in human skin keratinocytes as a possible mechanism for carcinogenesis associated with chronic arsenic exposure.

Authors:  S Huang; S Guo; F Guo; Q Yang; X Xiao; M Murata; S Ohnishi; S Kawanishi; N Ma
Journal:  Eur J Histochem       Date:  2013-01-14       Impact factor: 3.188

Review 4.  Meta-Analysis of Prognostic and Clinical Significance of CD44v6 in Esophageal Cancer.

Authors:  Bangli Hu; Wei Luo; Rui-Ting Hu; You Zhou; Shan-Yu Qin; Hai-Xing Jiang
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.889

Review 5.  Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?

Authors:  Rita Azevedo; Andreia Peixoto; Cristiana Gaiteiro; Elisabete Fernandes; Manuel Neves; Luís Lima; Lúcio Lara Santos; José Alexandre Ferreira
Journal:  Oncotarget       Date:  2017-07-21

6.  Preclinical evaluation of a novel engineered recombinant human anti-CD44v6 antibody for potential use in radio-immunotherapy.

Authors:  Anja C Mortensen; Diana Spiegelberg; Anna-Karin Haylock; Hans Lundqvist; Marika Nestor
Journal:  Int J Oncol       Date:  2018-04-11       Impact factor: 5.650

7.  Molecular characterization of low grade and high grade bladder cancer.

Authors:  Alessandro Apollo; Valerio Ortenzi; Cristian Scatena; Katia Zavaglia; Paolo Aretini; Francesca Lessi; Sara Franceschi; Sara Tomei; Carlo Alberto Sepich; Paolo Viacava; Chiara Maria Mazzanti; Antonio Giuseppe Naccarato
Journal:  PLoS One       Date:  2019-01-16       Impact factor: 3.240

8.  The clinicopathological and prognostic value of CD44 expression in bladder cancer: a study based on meta-analysis and TCGA data.

Authors:  Yu Hu; Yongrui Zhang; Jialin Gao; Xin Lian; Yuantao Wang
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

9.  Correlation of CD44v6 expression with ovarian cancer progression and recurrence.

Authors:  Jun Shi; Zhou Zhou; Wen Di; Ningli Li
Journal:  BMC Cancer       Date:  2013-04-08       Impact factor: 4.430

10.  The prognostic significance of CD44V6, CDH11, and β-catenin expression in patients with osteosarcoma.

Authors:  Zhouming Deng; Guangfeng Niu; Lin Cai; Renxiong Wei; Xiaolei Zhao
Journal:  Biomed Res Int       Date:  2013-07-18       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.